Show simple item record

dc.contributor.authorOsborne, Tanesha C.
dc.contributor.authorRoska, Rachel L. Weller
dc.contributor.authorRajski, Scott R.
dc.contributor.authorThompson, Paul R
dc.date2022-08-11T08:11:00.000
dc.date.accessioned2022-08-23T17:28:21Z
dc.date.available2022-08-23T17:28:21Z
dc.date.issued2008-04-09
dc.date.submitted2015-06-03
dc.identifier.citationJ Am Chem Soc. 2008 Apr 9;130(14):4574-5. doi: 10.1021/ja077104v. <a href="http://dx.doi.org/10.1021/ja077104v">Link to article on publisher's site</a>. Epub 2008 Mar 14.
dc.identifier.issn0002-7863 (Linking)
dc.identifier.doi10.1021/ja077104v
dc.identifier.urihttp://hdl.handle.net/20.500.14038/50062
dc.description<p>At the time of publication, Paul Thompson was not yet affiliated with UMass Medical School.</p>
dc.description.abstractProtein arginine methyltransferases (PRMTs) are (S)-adenosylmethionine (SAM)-dependent methyltransferases that catalyze the post-translational methylation of Arg residues in a variety of different proteins involved in transcriptional regulation and RNA splicing (e.g., histones H2A, H3, and H4). Herein, we describe the use of an N-mustard, 5'-(diaminobutyric acid)-N-iodoethyl-5'-deoxyadenosine ammonium hydrochloride (AAI), to generate a bisubstrate analogue inhibitor of PRMT1. Using the approach outlined in this communication, it should be possible to generate bisubstrate analogue-based inhibitors of PRMT isozymes that are potent and highly selective for a particular isozyme. The fact that PRMT1 catalyzes AAI transfer is also significant because with appropriate modifications (e.g., functionalization with pendant azido or alkyne functionalities) this compound could be used for proteomic applications to identify novel PRMT substrates.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=18338885&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1021/ja077104v
dc.subjectDeoxyadenosines
dc.subjectEnzyme Inhibitors
dc.subjectIsoenzymes
dc.subjectKinetics
dc.subjectPeptides
dc.subjectProtein-Arginine N-Methyltransferases
dc.subjectinhibitors
dc.subjectRepressor Proteins
dc.subjectSubstrate Specificity
dc.subjectBiochemistry
dc.subjectEnzymes and Coenzymes
dc.subjectMedicinal-Pharmaceutical Chemistry
dc.subjectTherapeutics
dc.titleIn situ generation of a bisubstrate analogue for protein arginine methyltransferase 1
dc.typeJournal Article
dc.source.journaltitleJournal of the American Chemical Society
dc.source.volume130
dc.source.issue14
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/thompson/69
dc.identifier.contextkey7172290
html.description.abstract<p>Protein arginine methyltransferases (PRMTs) are (S)-adenosylmethionine (SAM)-dependent methyltransferases that catalyze the post-translational methylation of Arg residues in a variety of different proteins involved in transcriptional regulation and RNA splicing (e.g., histones H2A, H3, and H4). Herein, we describe the use of an N-mustard, 5'-(diaminobutyric acid)-N-iodoethyl-5'-deoxyadenosine ammonium hydrochloride (AAI), to generate a bisubstrate analogue inhibitor of PRMT1. Using the approach outlined in this communication, it should be possible to generate bisubstrate analogue-based inhibitors of PRMT isozymes that are potent and highly selective for a particular isozyme. The fact that PRMT1 catalyzes AAI transfer is also significant because with appropriate modifications (e.g., functionalization with pendant azido or alkyne functionalities) this compound could be used for proteomic applications to identify novel PRMT substrates.</p>
dc.identifier.submissionpaththompson/69
dc.contributor.departmentDepartment of Biochemistry and Molecular Pharmacology
dc.source.pages4574-5


This item appears in the following Collection(s)

Show simple item record